Literature DB >> 10603398

Interleukin-12 as an adjuvant promotes immunoglobulin G and type 1 cytokine recall responses to major surface protein 2 of the ehrlichial pathogen Anaplasma marginale.

W Tuo1, G H Palmer, T C McGuire, D Zhu, W C Brown.   

Abstract

Anaplasma marginale is a tick-transmitted pathogen of cattle closely related to the human ehrlichiae, Ehrlichia chaffeensis and the agent of human granulocytic ehrlichiosis (HGE). These pathogens have in common a structurally conserved outer membrane protein (OMP) designated the major surface protein 2 (MSP-2) in A. marginale and HGE and OMP-1 in E. chaffeensis. Protective immunity against ehrlichial pathogens is believed to require induction of gamma interferon (IFN-gamma) and opsonizing immunoglobulin (Ig) subclasses directed against OMP epitopes that, in concert, activate macrophages for phagocytosis and killing. Because interleukin-12 (IL-12) acts as an adjuvant for protein immunization to induce IFN-gamma and protective immunity against intracellular pathogens, we hypothesized that as an adjuvant with MSP-2, IL-12 would augment type 1 recall responses to A. marginale. IL-12 was coadsorbed with MSP-2 to alum and shown to significantly enhance IFN-gamma production by lymph node cells (LNC) and LNC-derived CD4(+) T-cell lines from immunized calves following recall stimulation with A. marginale. LNC proliferation and IL-2 production were also enhanced in IL-12-treated calves. Elevated recall proliferative responses by peripheral blood mononuclear cells were still evident 9 months after immunization. Serum IgG levels were consistently increased in IL-12 immunized calves, predominantly due to higher IgG1 responses. The results support the use of IL-12 coadsorbed with OMP of ehrlichial pathogens in alum to amplify both antibody and type-1 cytokine responses important for protective immunity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10603398      PMCID: PMC97131          DOI: 10.1128/IAI.68.1.270-280.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  53 in total

1.  Immunization with Babesia bigemina rhoptry-associated protein 1 induces a type 1 cytokine response.

Authors:  B J Ruef; W Tuo; S D Rodriguez; A J Roussel; C G Chitko-McKown; G H Palmer; T F McElwain; A Canals; D S Zarlenga; L C Gasbarre; W C Brown
Journal:  J Interferon Cytokine Res       Date:  1997-01       Impact factor: 2.607

2.  Human interleukin-12 upregulates proliferation and interferon-gamma production by parasite antigen-stimulated Th cell clones and gamma/delta T cells of cattle.

Authors:  W C Brown; W C Davis; W Tuo
Journal:  Ann N Y Acad Sci       Date:  1996-10-31       Impact factor: 5.691

Review 3.  IL-12: a key cytokine in immune regulation.

Authors:  A G Lamont; L Adorini
Journal:  Immunol Today       Date:  1996-05

4.  Method for constructing internal standards for use in competitive PCR.

Authors:  D S Zarlenga; A Canals; L Gasbarre
Journal:  Biotechniques       Date:  1995-09       Impact factor: 1.993

5.  The adjuvant effect of interleukin-12 in a vaccine against Leishmania major.

Authors:  L C Afonso; T M Scharton; L Q Vieira; M Wysocka; G Trinchieri; P Scott
Journal:  Science       Date:  1994-01-14       Impact factor: 47.728

6.  Reactive oxygen and nitrogen intermediates and products from polyamine degradation are Babesiacidal in vitro.

Authors:  W C Johnson; C W Cluff; W L Goff; C R Wyatt
Journal:  Ann N Y Acad Sci       Date:  1996-07-23       Impact factor: 5.691

7.  Antibody against an Anaplasma marginale MSP5 epitope common to tick and erythrocyte stages identifies persistently infected cattle.

Authors:  D Knowles; S Torioni de Echaide; G Palmer; T McGuire; D Stiller; T McElwain
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

8.  CD4+ T-helper lymphocyte responses against Babesia bigemina rhoptry-associated protein I.

Authors:  S D Rodríguez; G H Palmer; T F McElwain; T C McGuire; B J Ruef; M G Chitko-McKown; W C Brown
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

9.  IL-12, as an adjuvant, promotes a T helper 1 cell, but does not suppress a T helper 2 cell recall response.

Authors:  J Bliss; V Van Cleave; K Murray; A Wiencis; M Ketchum; R Maylor; T Haire; C Resmini; A K Abbas; S F Wolf
Journal:  J Immunol       Date:  1996-02-01       Impact factor: 5.422

10.  Expression and biological activities of bovine interleukin 4: effects of recombinant bovine interleukin 4 on T cell proliferation and B cell differentiation and proliferation in vitro.

Authors:  D M Estes; A Hirano; V T Heussler; D A Dobbelaere; W C Brown
Journal:  Cell Immunol       Date:  1995-07       Impact factor: 4.868

View more
  10 in total

1.  Conservation of Babesia bovis small heat shock protein (Hsp20) among strains and definition of T helper cell epitopes recognized by cattle with diverse major histocompatibility complex class II haplotypes.

Authors:  Junzo Norimine; Juan Mosqueda; Guy H Palmer; Harris A Lewin; Wendy C Brown
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

2.  Quantitation of Anaplasma marginale major surface protein (MSP)1a and MSP2 epitope-specific CD4+ T lymphocytes using bovine DRB3*1101 and DRB3*1201 tetramers.

Authors:  Junzo Norimine; Sushan Han; Wendy C Brown
Journal:  Immunogenetics       Date:  2006-08-19       Impact factor: 2.846

3.  Babesia bovis-stimulated macrophages express interleukin-1beta, interleukin-12, tumor necrosis factor alpha, and nitric oxide and inhibit parasite replication in vitro.

Authors:  L K Shoda; G H Palmer; J Florin-Christensen; M Florin-Christensen; D L Godson; W C Brown
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

4.  Selective in vivo depletion of CD4(+) T lymphocytes with anti-CD4 monoclonal antibody during acute infection of calves with Anaplasma marginale.

Authors:  Reginald A Valdez; Travis C McGuire; Wendy C Brown; William C Davis; Jeffrey M Jordan; Donald P Knowles
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

5.  Anaplasma marginale major surface protein 2 CD4+-T-cell epitopes are evenly distributed in conserved and hypervariable regions (HVR), whereas linear B-cell epitopes are predominantly located in the HVR.

Authors:  Jeffrey R Abbott; Guy H Palmer; Chris J Howard; Jayne C Hope; Wendy C Brown
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

Review 6.  Antigens and alternatives for control of Anaplasma marginale infection in cattle.

Authors:  Katherine M Kocan; José de la Fuente; Alberto A Guglielmone; Roy D Meléndez
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

7.  Stimulation of T-helper cell gamma interferon and immunoglobulin G responses specific for Babesia bovis rhoptry-associated protein 1 (RAP-1) or a RAP-1 protein lacking the carboxy-terminal repeat region is insufficient to provide protective immunity against virulent B. bovis challenge.

Authors:  Junzo Norimine; Juan Mosqueda; Carlos Suarez; Guy H Palmer; Terry F McElwain; Gabriel Mbassa; Wendy C Brown
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

8.  Association of tuberculin-boosted antibody responses with pathology and cell-mediated immunity in cattle vaccinated with Mycobacterium bovis BCG and infected with M. bovis.

Authors:  Konstantin Lyashchenko; Adam O Whelan; Rena Greenwald; John M Pollock; Peter Andersen; R Glyn Hewinson; H Martin Vordermeier
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

9.  Regional immune response to immunization with Escherichia coli O157:H7-derived intimin in cattle.

Authors:  Kathryn G Boland; Andrea N Hayles; Claire B Miller; Tovah Kerr; Wendy C Brown; Kevin K Lahmers
Journal:  Clin Vaccine Immunol       Date:  2013-02-13

10.  CD4+ T lymphocytes from Anaplasma marginale major surface protein 2 (MSP2) vaccinees recognize naturally processed epitopes conserved in MSP3.

Authors:  Wendy C Brown; Guy H Palmer; Kelly A Brayton; Patrick F M Meeus; Anthony F Barbet; Kimberly A Kegerreis; Travis C McGuire
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.